BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 21397280)

  • 1. [Nephrogenic systemic fibrosis and gadolinium contrast agents].
    Aguilera C; Agustí A
    Med Clin (Barc); 2011 May; 136(14):643-5. PubMed ID: 21397280
    [No Abstract]   [Full Text] [Related]  

  • 2. Nephrogenic systemic fibrosis: the need for accurate case reporting.
    Spinazzi A; Kirchin MA; Pirovano G
    J Magn Reson Imaging; 2009 May; 29(5):1240; author reply 1241. PubMed ID: 19388104
    [No Abstract]   [Full Text] [Related]  

  • 3. Nephrogenic systemic fibrosis: possible mechanisms and imaging management strategies.
    Dawson P
    J Magn Reson Imaging; 2008 Oct; 28(4):797-804. PubMed ID: 18821621
    [No Abstract]   [Full Text] [Related]  

  • 4. Nephrogenic systemic fibrosis and gadolinium: a cautionary tale in the molecular imaging era.
    Wang SC
    J Med Imaging Radiat Oncol; 2008 Aug; 52(4):305-6. PubMed ID: 18811752
    [No Abstract]   [Full Text] [Related]  

  • 5. Nephrogenic systemic fibrosis.
    Weinreb JC; Kuo PH
    Magn Reson Imaging Clin N Am; 2009 Feb; 17(1):159-67. PubMed ID: 19364606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Risk of Nephrogenic Systemic Fibrosis in Group II and III Gadolinium-Based Contrast Agents.
    Costa AF
    Can Assoc Radiol J; 2020 Nov; 71(4):536. PubMed ID: 32063014
    [No Abstract]   [Full Text] [Related]  

  • 7. Safety of magnetic resonance contrast media: a review with special focus on nephrogenic systemic fibrosis.
    Haneder S; Kucharczyk W; Schoenberg SO; Michaely HJ
    Top Magn Reson Imaging; 2015 Feb; 24(1):57-65. PubMed ID: 25654421
    [No Abstract]   [Full Text] [Related]  

  • 8. [Causal relationship between the use of gadolinium based contrast media and nephrogenic systemic fibrosis].
    Varela CU; Prieto-Rayo JC
    Rev Med Chil; 2014 Dec; 142(12):1565-74. PubMed ID: 25693439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gadolinium-associated nephrogenic systemic fibrosis.
    Schlaudecker JD; Bernheisel CR
    Am Fam Physician; 2009 Oct; 80(7):711-4. PubMed ID: 19817341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylactic Hemodialysis for Protection Against Gadolinium-Induced Nephrogenic Systemic Fibrosis: A Doll's House.
    Yee J
    Adv Chronic Kidney Dis; 2017 May; 24(3):133-135. PubMed ID: 28501073
    [No Abstract]   [Full Text] [Related]  

  • 11. Gadolinium and nephrogenic systemic fibrosis.
    Runge VM
    AJR Am J Roentgenol; 2009 Apr; 192(4):W195-6; discussion W197. PubMed ID: 19304681
    [No Abstract]   [Full Text] [Related]  

  • 12. Nephrogenic systemic fibrosis: a review of the new conundrum.
    Goenka AH; Das CJ; Sharma R
    Natl Med J India; 2009; 22(6):302-6. PubMed ID: 20384019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Gadolinium and nephrogenic systemic fibrosis. All quiet? Yes...! No...! Maybe...!].
    Balducci A; Tamburrini O
    G Ital Nefrol; 2011; 28(1):4-6. PubMed ID: 21341233
    [No Abstract]   [Full Text] [Related]  

  • 14. Nephrogenic systemic fibrosis and gadolinium-containing radiological contrast agents: an update.
    Jalandhara N; Arora R; Batuman V
    Clin Pharmacol Ther; 2011 Jun; 89(6):920-3. PubMed ID: 21471962
    [No Abstract]   [Full Text] [Related]  

  • 15. Recent topics related to nephrogenic systemic fibrosis associated with gadolinium-based contrast agents.
    Kitajima K; Maeda T; Watanabe S; Ueno Y; Sugimura K
    Int J Urol; 2012 Sep; 19(9):806-11. PubMed ID: 22571387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How to avoid nephrogenic systemic fibrosis: current guidelines in Europe and the United States.
    Thomsen HS
    Radiol Clin North Am; 2009 Sep; 47(5):871-5, vii. PubMed ID: 19744601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NSF: still relevant.
    Thomsen HS
    J Magn Reson Imaging; 2014 Jul; 40(1):11-2. PubMed ID: 24990765
    [No Abstract]   [Full Text] [Related]  

  • 18. Experimental studies investigating the pathophysiology of nephrogenic systemic fibrosis; what did we learn so far?
    Morcos SK
    Eur Radiol; 2011 Mar; 21(3):496-500. PubMed ID: 20848109
    [No Abstract]   [Full Text] [Related]  

  • 19. Gadolinium and nephrogenic systemic fibrosis: have the alarm bells been silenced?
    Tamburrini O; Balducci A
    Radiol Med; 2012 Feb; 117(1):1-5. PubMed ID: 22020430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Focus on contrast-associated nephrogenic systemic fibrosis.
    Partain CL
    J Magn Reson Imaging; 2009 Dec; 30(6):1231-2. PubMed ID: 19938033
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.